6 Jan 2014 07:00
6 January 2014
Phorm Corporation Limited ("Phorm" or the "Company")
Exercise of Employee Warrants for Shares
Phorm (AIM: PHRM), a leading internet personalization technology company, announces today that it has issued 150,000 ordinary shares of nil par value in the capital of the Company further to the exercise of warrants for shares previously issued to employees.
Application will be made for the shares to be admitted to trading on AIM and trading is expected to commence at 8.00am on 9 January 2014.
Following the issue, the total issued share capital of the Company will comprise 529,483,695 ordinary shares.
-ends-
Contact
Phorm Corporation Limited
Andy Croxson (analysts & investors) +44 207 297 2067
UK Investors
Mirabaud Securities LLP +44 20 7321 2508 (Joint Broker)
Jason Woollard
Peter Krens
Liberum Capital +44 20 3100 2222 (Nominated Advisor and Joint Broker)
Chris Bowman
Richard Bootle
US Investors
Lippert Heilshorn and Associates +1 212 838 3777 (Investor Relations)
John Heilshorn
About Phorm
Phorm is a global personalization technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.
Phorm's industry leading technology enables its ISP partners to offer a new type of online advertising platform and a free consumer internet content feature, ensuring more relevant advertisements and personalized content for opted-in users.
Phorm's advertising platform revolutionizes current standards of online privacy, fully protecting the identity of consumers. Unlike virtually all other targeted advertising propositions, Phorm's solution is completely opt-in. Only those users consenting to the service are profiled and only ever on an anonymous basis.
Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Advertising Networks and Advertisers.
Phorm, under a predecessor holding company, was admitted to the AIM market of the London Stock Exchange in 2004.
For more information, please visit: www.phorm.com